Jean-Marie Eveillard - First Eagle Investment Management
Holding/activity history for Health Catalyst Inc (HCAT)
← All HCAT superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2023 Q3 | 0 | 0.00 | Sell 100.00% | <0.01 | $9.25–14.37 · VW $11.87i | SEC | |
| 2023 Q2 | 82,123 | <0.01 | Reduce 24.48% | <0.01 | $9.45–13.34 · VW $11.86i | $1,026,538 | SEC |
| 2023 Q1 | 108,740 | <0.01 | Reduce 38.82% | <0.01 | $9.90–15.87 · VW $12.87i | $1,268,996 | SEC |
| 2022 Q4 | 177,740 | 0.01 | Reduce 36.58% | <0.01 | $6.40–11.64 · VW $9.37i | $1,889,376 | SEC |
| 2022 Q3 | 280,240 | 0.01 | Buy | 0.01 | $9.03–18.30 · VW $12.67i | $2,718,000 | SEC |